Milacron Holdings Corp. Common (NYSE:MCRN) has been the object of insider selling activity recently. Ira G. Boots, Director disclosed the sale of 64,806 shares. The shares were purchased at an average price of $18.30. The Director now owns $0 of the stock per the Form 4 SEC filing. Ronald M. Krisanda, President and COO let go of $342,942 worth of shares at an average price of $18.30 on Thu the 8th. That brings Krisanda’s holdings to $1,382,583 per an SEC filing yesterday.
Director Jim M. Kratochvil let go of 15,800 shares at an average price of $17.99 on June 2nd. Kratochvil now owns $132,191 of stock as recorded in a recent Form 4 SEC filing.
Milacron Holdings Corp., launched on March 16, 2012, is involved in the manufacture, distribution, and service of engineered and customized systems used in the plastic technology and processing industry. The Company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies. The Company has a product portfolio that includes hot runner systems, injection molding, blow molding and extrusion equipment. It produces process control systems, mold bases and components, and maintenance, repair and operating (MRO) supplies and fluid technology. As of December 31, 2016, the Business’s products were sold in over 100 countries across six continents. Its customers include original equipment manufacturers (OEMs), molders and mold-makers. Its customer base covers a range of end-market applications, including packaging, automotive, medical, construction, consumer goods and electronics..
Here are a few additional firms who have increased or decreased their stake in (MCRN). Levin Capital Strategies, L.p. bolstered its stake by buying 617,406 shares an increase of 17.6% in the quarter. Levin Capital Strategies, L.p. currently owns 4,129,482 shares with a value of $76,850,000. The total value of its holdings increased 17.5%. As of quarter end Morgan Stanley had disposed of 50 shares trimming its stake by 29.2%. The value of the investment in MCRN decreased from $3,000 to $2,000 decreasing 33.3% since the last quarter.
As of the end of the quarter Goldman Sachs Group Inc had bought a total of 43,649 shares growing its position 383.5%. The value of the investment in (MCRN) went from $212,000 to $1,024,000 a change of $812,000 for the reporting period. As of quarter end Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Management Corp had sold a total of 2,170,751 shares trimming its holdings by 27.2%. The value of the investment in Milacron Holdings Corp. Common went from $148,528,000 to $107,971,000 a change of 27.3% quarter over quarter.
March 3 investment analysts at Baird held the company rating at “Outperform” and raised the price target to $18.00 from $17.00. On October 5 Barclays made no change to the stock rating of “Overweight” but lowered the price expectation from $25.00 to $21.00.
Equity analyst Baird started covering MCRN giving it an initial rating of “Outperform” and establishing a price target of $24.00. Barclays starting coverage on the stock with an initial rating of “Overweight” and setting a price target of $25.00.
On August 4 analysts at William Blair began coverage of the stock setting a rating of “Outperform”. On August 4, 2015 Goldman Sachs issued its first research report on the stock by announcing an initial rating of “Neutral” and price target of $19.00.
The company is so far trading down from yesterday’s close of $18.7. The stock is trading at $18.64 just a bit higher than $17.79, the 50 day moving average and a bit higher than the 200 day moving average of $18.02. The 50 day moving average went up by +4.90% and the 200 day average moved up $0.64.
As of the last earnings report the EPS was $-0.06 and is estimated to be $1.60 for the current year with 69,089,000 shares currently outstanding. Next quarter’s EPS is estimated at $0.42 with next year’s EPS anticipated to be $1.74.